Skip to main content
Equibles

JUPITER ASSET MANAGEMENT LTD

Position in EXEL — Exelixis, Inc.

CIK 1215838 London, X0
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$211,818
-$41,280,353 QoQ
Shares Held
3,893
-99.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#580
of 756 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JUPITER ASSET MANAGEMENT LTD holds $354,007,590 across 28 Biotechnology names. EXEL ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 126,099 $78,627,770
2 INCY
Incyte Corp
 511,050 $57,932,627
3 PTCT
Ptc Therapeutics, Inc.
 707,450 $57,706,695
4 NTLA
Intellia Therapeutics, Inc.
 1,849,507 $31,293,657
5 IOVA
Iovance Biotherapeutics, Inc.
 4,535,080 $18,865,932
6 AUPH
Aurinia Pharmaceuticals Inc.
 1,094,475 $18,573,240
7 BEAM
Beam Therapeutics Inc.
 445,718 $15,297,041
8 RLAY
Relay Therapeutics, Inc.
 719,576 $13,463,266

All Filings in EXEL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $211,818 3,893
2026-03-31 $41,492,171 967,409
2025-12-31 $89,312,302 2,037,698
2025-09-30 $87,222,832 2,111,933
2025-06-30 $46,721,493 1,059,925
2025-03-31 $51,697,968 1,400,270
2024-12-31 $13,984,368 419,951
2024-09-30 $58,050,461 2,237,012
2024-06-30 $50,959,577 2,267,894
2024-03-31 $53,817,123 2,267,894
2023-12-31 $21,922,828 913,832
2023-06-30 $899,087 47,048
2022-09-30 $221,150 14,104
2021-06-30 $3,826,200 210,000
2021-03-31 $4,743,900 210,000
2020-12-31 $3,612,600 180,000
2020-09-30 $4,401,000 180,000